BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36206810)

  • 21. [Clinical analysis of 82 cases of generalized pustular psoriasis].
    Wu X; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Feb; 42(2):173-178. PubMed ID: 28255119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis.
    Zheng M; Jullien D; Eyerich K
    Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):5-12. PubMed ID: 35061224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence, incidence, mortality, and healthcare resource use for generalised pustular psoriasis, palmoplantar pustulosis, and plaque psoriasis in England: a population-based cohort study.
    Frysz M; Patel S; Li MOY; Griffiths CEM; Warren RB; Ashcroft DM
    Br J Dermatol; 2024 May; ():. PubMed ID: 38775029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvements in the Management of Patients With Generalized Pustular Psoriasis in Spain: Recommendations From a Group of Experts.
    Rivera-Díaz R; Carrascosa Carrillo JM; Alfonso Zamora S; Navarro Valdivieso JP; Muñoz Cabello B; Ros Abarca S; de Francisco JMS; Daudén Tello E
    Actas Dermosifiliogr; 2024 Jul; ():. PubMed ID: 38972580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States.
    Hanna ML; Singer D; Valdecantos WC
    Curr Med Res Opin; 2021 May; 37(5):735-742. PubMed ID: 33622113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A brief guide to pustular psoriasis for primary care providers.
    Crowley JJ; Pariser DM; Yamauchi PS
    Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States.
    Noe MH; Wan MT; Mostaghimi A; Gelfand JM; ; Agnihothri R; Armstrong AW; Bhutani T; Bridges A; Brownstone N; Butt M; Duffin KPC; Carr C; Creadore A; DeNiro KL; Desai S; Dominguez AR; Duffy EK; Fairley JA; Femia A; Gudjonsson JE; Kaffenberger JA; Katz KL; Le ST; Martinez E; Maverakis E; Myers B; Naik HB; Nelson CA; Ortega-Loayza AG; Plovanich ME; Rangel LK; Ravi V; Reddy VD; Saleh JZ; Kirby JS; Sandhu JK; Shakshouk H; Shields BE; Sharif-Sidi Z; Smith J; Steahr A; Toussi A; Wanat KA; Wang B; Wei BM; Weinhammer A; Worswick SD; Yang A
    JAMA Dermatol; 2022 Jan; 158(1):73-78. PubMed ID: 34878491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The burden associated with generalized pustular psoriasis: A Canadian population-based study of inpatient care, emergency departments, and hospital- or community-based outpatient clinics.
    Tarride JE; Prajapati VH; Lynde C; Blackhouse G
    JAAD Int; 2023 Sep; 12():90-98. PubMed ID: 37325044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diversity in the clinical presentation of generalized pustular psoriasis (GPP): A series of case vignettes from around the world.
    Choon SE; Elewski BE; Fujita H; Geng S; van de Kerkhof P; Mburu S; Puig L; Romiti R; Venturini M
    Exp Dermatol; 2023 Aug; 32(8):1284-1295. PubMed ID: 36999936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.
    Sugiura K
    J Dermatol Sci; 2014 Jun; 74(3):187-92. PubMed ID: 24656634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and genetic differences between pustular psoriasis subtypes.
    Twelves S; Mostafa A; Dand N; Burri E; Farkas K; Wilson R; Cooper HL; Irvine AD; Oon HH; Kingo K; Köks S; Mrowietz U; Puig L; Reynolds N; Tan ES; Tanew A; Torz K; Trattner H; Valentine M; Wahie S; Warren RB; Wright A; Bata-Csörgő Z; Szell M; Griffiths CEM; Burden AD; Choon SE; Smith CH; Barker JN; Navarini AA; Capon F
    J Allergy Clin Immunol; 2019 Mar; 143(3):1021-1026. PubMed ID: 30036598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvements in the Management of Patients With Generalized Pustular Psoriasis in Spain: Recommendations From a Group of Experts.
    Rivera-Díaz R; Carrascosa Carrillo JM; Alfonso Zamora S; Navarro Valdivieso JP; Muñoz Cabello B; Ros Abarca S; Soria de Francisco JM; Daudén Tello E
    Actas Dermosifiliogr; 2024 May; ():. PubMed ID: 38777227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records.
    Zema CL; Valdecantos WC; Weiss J; Krebs B; Menter AM
    JAMA Dermatol; 2022 Oct; 158(10):1142-1148. PubMed ID: 35947363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased level of high mobility group box 1 in the serum and skin in patients with generalized pustular psoriasis.
    Watanabe T; Yamaguchi Y; Watanabe Y; Takamura N; Aihara M
    J Dermatol; 2020 Sep; 47(9):1033-1036. PubMed ID: 32613742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion.
    Bachelez H; Barker J; Burden AD; Navarini AA; Krueger JG
    Expert Rev Clin Immunol; 2022 Oct; 18(10):1033-1047. PubMed ID: 36062811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis.
    Morita A; Choon SE; Bachelez H; Anadkat MJ; Marrakchi S; Zheng M; Tsai TF; Turki H; Hua H; Rajeswari S; Thoma C; Burden AD
    Dermatol Ther (Heidelb); 2023 Jan; 13(1):347-359. PubMed ID: 36333618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
    Menter A; Van Voorhees AS; Hsu S
    Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Juvenile generalized pustular psoriasis is a chronic recalcitrant disease: an analysis of 27 patients seen in a tertiary hospital in Johor, Malaysia.
    Lau BW; Lim DZ; Capon F; Barker JN; Choon SE
    Int J Dermatol; 2017 Apr; 56(4):392-399. PubMed ID: 28194751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of Generalized Pustular Psoriasis.
    Fujita H; Gooderham M; Romiti R
    Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):31-38. PubMed ID: 35061226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis.
    Morita A; Okubo Y; Morisaki Y; Torisu-Itakura H; Umezawa Y
    Dermatol Ther (Heidelb); 2022 Feb; 12(2):481-494. PubMed ID: 34967916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.